Oxford Biomedica. 2005 to see 'Huge value creation' (Panmure Gordon)

Hector,
congrats on taking your profits up at 44p - hats off to you .
As you know , I don't trade OXB , just add to core long term holding when I can, but I agree with you that this is a very strong buy down here now.

What has changed this week ?

Well we have had four positive RNS's . Two of them establishing the efficacy of OXB's lead oncology products in phase II trials , another a commercial deal with upfront money and annual payments with a global leader in the reagents market , and the fourth proving that the partnership with Wyeth is on its way to the clinic - yielding $24 million for OXB plus single digit royalties on a potential cancer blockbuster.
And....the share price has fallen 25% .
Of course you can never fight the market . The laws of supply and demand will win out in the end , but I am at a loss to understand why we are down here at 33.5p , I must admit.
I confidently expect an impressive bounce next week , now that all of the margin players have been forced out , and long term holders and institutions can take advantage of this bargain price.

Tuco.